# Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions

> **NCT03050164** · PHASE1 · COMPLETED · sponsor: **Hunan Kelun Pharmaceutical Co., Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** Gefitinib Tablet 250mg of Hunan Kelun
- **DRUG:** Iressa® Tablet 250mg of AZN

## Key facts

- **NCT ID:** NCT03050164
- **Lead sponsor:** Hunan Kelun Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-08
- **Primary completion:** 2016-11-04
- **Final completion:** 2016-11-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03050164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03050164, "Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03050164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*